CompletedNot Applicable

PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma

United Kingdom9 participantsStarted 2024-04-05

Plain-language summary

This is a qualitative (interview) study to explore the experiences of people receiving treatment for MM and to understand what matters most to participants when making treatment decisions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Participants with confirmed MM (per standard disease specific diagnostic criteria)
✓. Participants must have received ≥ 5 lines of treatment for MM and fit into one of the below treatment categories:
✓. Subset 1- Participants must have received an oral anti-cancer therapy and a bi-specific antibody treatment.
✓. Subset 2- Participants must have received an oral anti-cancer therapy and if they have not had a bi-specific antibody treatment, they must have received at least one IV therapy.
✓. Aged 18 years of age or over
✓. Able to provide informed consent
✓. Able to communicate in English

Exclusion criteria

✕. Aged under 18
✕. Unable to understand and communicate in the English language
✕. Unable to provide written informed consent

What they're measuring

Patient Experience and Preference

Timeframe: 30-60 minutes

Trial details

NCT IDNCT06322927

SponsorThe Christie NHS Foundation Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-30

View on ClinicalTrials.gov More Multiple Myeloma trials